Abstract
Background: Myeloid-derived suppressor cells (MDSCs) are immunosuppressive in nature, originate in the bone marrow, and are mainly found in the blood, spleen, and liver. In fact, liver acts as an important organ for induction and accumulation of MDSCs, especially during infection, inflammation, and cancer. In humans and rodents, models of liver diseases revealed that MDSCs promote regeneration and drive the inflammatory processes, leading to hepatitis, fibrogenesis, and cirrhosis, ultimately resulting in hepatocellular carcinoma. Summary: This brief review is focused on the in-depth understanding of the key molecules involved in the expansion and regulation of MDSCs and their underlying immunosuppressive mechanisms in liver diseases. Key Message: Modulated MDSCs can be used for therapeutic purposes in inflammation, cancer, and sepsis.
References
1.
Gabrilovich
DI
, Nagaraj
S
. Myeloid-derived suppressor cells as regulators of the immune system
. Nat Rev Immunol
. 2009
;9
(3
):162
–74
. .2.
Pallet
JL
, Gill
US
, Quaglia
A
, Sinclair
LV
, Jover-Cobos
M
, Schurich
A
, Metabolic regulation of hepatitis B immunopathology by myeloid derived suppressor cells
. Nat Med
. 2015
;21
:591
–600
.3.
Youn
JI
, Nagaraj
S
, Collazo
M
, Gabrilovich
DI
. Subsets of myeloid-derived suppressor cells in tumor-bearing mice
. J Immunol
. 2008
;181
(8
):5791
–802
. .4.
Poschke
I
, Mougiakakos
D
, Hansson
J
, Masucci
GV
, Kiessling
R
. Immature immunosuppressive CD14+ HLA−DR−/low cells in melanoma patients are Stat3hi and overexpress CD80, CD83, and DC−sign
. Cancer Res
. 2010
;70
:4335
–45
.5.
IIlovitch
D
, Lopez
DM
. The liver is a site for tumor induced myeloid derived suppressor cell accumulation and immunosuppression
. Can Res
. 2009
;69
:5514
–21
.6.
Yen
BL
, Yen
ML
, Hsu
PJ
, Liu
KJ
, Wang
CJ
, Bai
CH
, Multipotent human mesenchymal stromal cells mediate expansion of myeloid-derived suppressor cells via hepatocyte growth factor/c-met and STAT3
. Stem Cell Rep
. 2013
;1
(2
):139
–51
. .7.
Gargett
T
, Christo
SN
, Hercus
TR
, Abbas
N
, Singhal
N
, Lopez
AF
, GM-CSF signalling blockade and chemotherapeutic agents act in concert to inhibit the function of myeloid-derived suppressor cells in vitro
. Clin Transl Immunology
. 2016
;5
(12
):e119
. .8.
Holmgaard
RB
, Zamarin
D
, Lesokhin
A
, Merghoub
T
, Wolchok
JD
. Targeting myeloid-derived suppressor cells with colony stimulating factor-1 receptor blockade can reverse immune resistance to immunotherapy in indoleamine 2,3-dioxygenase-expressing tumors
. EBioMedicine
. 2016
;6
:50
–8
. .9.
Noman
MZ
, Desantis
G
, Janji
B
, Hasmim
M
, Karray
S
, Dessen
P
, PD-L1 is a novel direct target of HIF-1α, and its blockade under hypoxia enhanced MDSC-mediated T cell activation
. J Exp Med
. 2014
;211
(5
):781
–90
. .10.
Sander
LE
, Sackett
SD
, Dierssen
U
, Beraza
N
, Linke
RP
, Müller
M
, Hepatic acute-phase proteins control innate immune responses during infection by promoting myeloid-derived suppressor cell function
. J Exp Med
. 2010
;207
(7
):1453
–64
. .11.
Lee
JM
, Kim
EK
, Seo
H
, Jeon
I
, Chae
MJ
, Park
YJ
, Serum amyloid A3 exacerbates cancer by enhancing the suppressive capacity of myeloid-derived suppressor cells via TLR2-dependent STAT3 activation
. Eur J Immunol
. 2014
;44
(6
):1672
–84
. .12.
Xu
Y
, Zhao
W
, Xu
J
, Li
J
, Hong
Z
, Yin
Z
, Activated hepatic stellate cells promote liver cancer by induction of myeloid-derived suppressor cells through cyclooxygenase-2
. Oncotarget
. 2016
;7
(8
):8866
. .13.
Liu
M
, Zhou
J
, Liu
X
, Feng
Y
, Yang
W
, Wu
F
, Targeting monocyte-intrinsic enhancer reprogramming improves immunotherapy efficacy in hepatocellular carcinoma
. Gut
. 2020
;69
(2
):365
–79
.14.
Hӧchst
B
, Schildberg
FA
, Sauerborn
P
, Gäbel
YA
, Gevensleben
H
, Goltz
D
, Activated human hepatic stellate cells induce myeloid derived suppressor cells from peripheral blood monocytes in a CD44-dependent fashion
. J Hepatol
. 2013
;59
:528
–35
.15.
Resheq
YJ
, Li
KK
, Ward
ST
, Wilhelm
A
, Garg
A
, Curbishley
SM
, Contact-dependent depletion of hydrogen peroxide by catalase is a novel mechanism of myeloid-derived suppressor cell induction operating in human hepatic stellate cells
. J Immunol
. 2015
;194
(6
):2578
–86
. .16.
Chou
HS
, Hsieh
CC
, Yang
HR
, Wang
L
, Arakawa
Y
, Brown
K
, Hepatic stellate cells regulate immune response by way of induction of myeloid suppressor cells in mice
. Hepatology
. 2011
;53
(3
):1007
–19
. .17.
Hsieh
CC
, Chou
HS
, Yang
HR
, Lin
F
, Bhatt
S
, Qin
J
, The role of complement component 3 (C3) in differentiation of myeloid-derived suppressor cells
. Blood
. 2013
;121
(10
):1760
–8
. .18.
Cauley
LS
, Miller
EE
, Yen
M
, Swain
SL
. Superantigen-induced CD4 T cell tolerance mediated by myeloid cells and IFN-gamma
. J Immunol
. 2000
;165
(11
):6056
–66
. .19.
Raber
PL
, Thevenot
P
, Sierra
R
, Wyczechowska
D
, Halle
D
, Ramirez
ME
, Subpopulations of myeloid-derived suppressor cells impair T cell responses through independent nitric oxide-related pathways
. Int J Cancer
. 2014
;134
(12
):2853
–64
. .20.
Gallina
G
, Dolcetti
L
, Serafini
P
, De Santo
C
, Marigo
I
, Colombo
MP
, Tumors induce a subset of inflammatory monocytes with immunosuppressive activity on CD8+ T cells
. J Clin Invest
. 2006
;116
(10
):2777
–90
. .21.
Lee
CR
, Kwak
Y
, Yang
T
, Han
JH
, Park
SH
, Ye
MB
, Myeloid-derived suppressor cells are controlled by regulatory T cells via TGF-β during murine colitis
. Cell Rep
. 2016
;17
(12
):3219
–32
. .22.
Lechner
MG
, Megiel
C
, Russell
SM
, Bingham
B
, Arger
N
, Woo
T
, Functional characterization of human Cd33+ and Cd11b+ myeloid-derived suppressor cell subsets induced from peripheral blood mononuclear cells co-cultured with a diverse set of human tumor cell lines
. J Transl Med
. 2011
;9
:90
. .23.
Serafini
P
, Meckel
K
, Kelso
M
, Noonan
K
, Califano
J
, Koch
W
, Phosphodiesterase-5 inhibition augments endogenous antitumor immunity by reducing myeloid-derived suppressor cell function
. J Exp Med
. 2006
;203
(12
):2691
–702
. .24.
Diao
W
, Jin
F
, Wang
B
, Zhang
C-Y
, Chen
J
, Zen
K
, The protective role of myeloid-derived suppressor cells in concanavalin A-induced hepatic injury
. Protein Cell
. 2014
;5
(9
):714
–24
. .25.
Sarra
M
, Cupi
ML
, Bernardini
R
, Ronchetti
G
, Monteleone
I
, Ranalli
M
, IL-25 prevents and cures fulminant hepatitis in mice through a myeloid-derived suppressor cell-dependent mechanism
. Hepatology
. 2013
;58
(4
):1436
–50
. .26.
Zhang
H
, Lian
M
, Zhang
J
, Bian
Z
, Tang
R
, Miao
Q
, A functional characteristic of cysteine-rich protein 61: modulation of myeloid-derived suppressor cells in liver inflammation
. Hepatology
. 2018
;67
(1
):232
–46
. .27.
Li
ZQ
, Wu
WR
, Zhao
C
, Zhao
C
, Zhang
X-L
, Yang
Z
, CCNI/Cyr61 enhances the function of hepatic stellate cells in promoting the progression of hepatocellular carcinoma
. Int J Mol Med
. 2018
;41
:1518
–28
.28.
Ju
L
, Sun
Y
, Xue
H
, Chen
L
, Gu
C
, Shao
J
, CCN1 promotes hepatic steatosis and inflammation in non-alcoholic steatohepatitis
. Sci Rep
. 2020
;10
(1
):3201
. .29.
Suh
YG
, Kim
JK
, Byun
JS
, Yi
HS
, Lee
YS
, Eun
HS
, CD11b(+) Gr1(+) bone marrow cells ameliorate liver fibrosis by producing interleukin-10 in mice
. Hepatology
. 2012
;56
(5
):1902
–12
. .30.
Huang
A
, Zhang
B
, Yan
W
, Wang
B
, Wei
H
, Zhang
F
, Myeloid-derived suppressor cells regulate immune response in patients with chronic hepatitis B virus infection through PD-1-Induced IL-10
. J Immunol
. 2014
;193
(11
):5461
–9
. .31.
Chen
S
, Akbar
SMF
, Abe
M
, Hiasa
Y
, Onji
M
. Immunosuppressive functions of hepatic myeloid-derived suppressor cells of normal mice and in a murine model of chronic hepatitis B virus
. Clin Exp Immunol
. 2011
;166
(1
):134
–42
. .32.
Sandalova
E
, Laccabue
D
, Boni
C
, Watanabe
T
, Tan
A
, Zong
HZ
, Increased levels of arginase in patients with acute hepatitis B suppress antiviral T cells
. Gastroenterology
. 2012
;143
(1
):78
–e3
. .33.
Rodriguez
PC
, Quiceno
DG
, Ochoa
AC
. L-arginine availability regulates T-lymphocyte cell-cycle progression
. Blood
. 2007
;109
(4
):1568
–73
. .34.
Kong
X
, Sun
R
, Chen
Y
, Wei
H
, Tian
Z
. γδT cells drive myeloid-derived suppressor cell-mediated CD8+ T cell exhaustion in hepatitis B virus-induced immunotolerance
. J Immunol
. 2014
;193
(4
):1645
–53
. .35.
Ren
JP
, Zhao
J
, Dai
J
, Griffin
JW
, Wang
L
, Wu
XY
, Hepatitis C virus-induced myeloid-derived suppressor cells regulate T-cell differentiation and function via the signal transducer and activator of transcription 3 pathway
. Immunology
. 2016
;148
(4
):377
–86
. .36.
Zeng
QL
, Yang
B
, Sun
HQ
, Feng
GH
, Jin
L
, Zou
ZS
, Myeloid-derived suppressor cells are associated with viral persistence and downregulation of TCR ζ chain expression on CD8(+) T cells in chronic hepatitis C patients
. Mol Cells
. 2014
;37
(1
):66
. .37.
Ren
JP
, Zhao
J
, Dai
J
, Griffin
JW
, Wang
L
, Wu
XY
, Hepatitis C virus-induced myeloid-derived suppressor cells regulate T-cell differentiation and function via the signal transducer and activator of transcription 3 pathway
. Immunology
. 2016
;148
(4
):377
–86
. .38.
Salem
ML
, Zidan
AA
, Attia
M
, El-Naggar
RE
, Nassef
M
, Abou El-Azm
AR
, IFN-α-based treatment of patients with chronic HCV show increased levels of cells with myeloid-derived suppressor cell phenotype and of IDO and NOS
. Immunopharmacol Immunotoxicol
. 2017
;39
(4
):188
–98
. .39.
Czaja
AJ
. Understanding the pathogenesis of autoimmune hepatitis
. Am J Gastroenterol
. 2001
;96
(4
):1224
. .40.
Li
H
, Dai
F
, Peng
Q
, Gan
H
, Zheng
J
, Xia
Y
, Myeloid-derived suppressor cells suppress CD4+ and CD8+ T cell responses in autoimmune hepatitis
. Mol Med Rep
. 2015
;12
:3667
–73
.41.
Cripps
JG
, Wang
J
, Maria
A
, Blumenthal
I
, Gorham
JD
. Type 1 T helper cells induce the accumulation of myeloid-derived suppressor cells in the inflamed Tgfb1 knockout mouse liver
. Hepatology
. 2010
;52
(4
):1350
–9
. .42.
Joyce
D
, Fujino
M
, Morita
M
, Araki
R
, Fung
J
, Qian
S
, Induced pluripotent stem cells-derived myeloid-derived suppressor cells regulate the CD8+ T cell response
. Stem Cell Res
. 2018
;29
:32
–41
. .43.
Hammerich
L
, Warzecha
KT
, Stefkova
M
, Bartneck
M
, Ohl
K
, Gassler
N
, Cyclic adenosine monophosphate-responsive element modulator alpha overexpression impairs function of hepatic myeloid-derived suppressor cells and aggravates immune-mediated hepatitis in mice
. Hepatology
. 2015
;61
(3
):990
–1002
. .44.
Darcy
CJ
, Minigo
G
, Piera
KA
, Davis
JS
, McNeil
YR
, Chen
Y
, Neutrophils with myeloid derived suppressor function deplete arginine and constrain T cell function in septic shock patients
. Critical Care
. 2014
;18
(4
):R163
. .45.
Tracey
KJ
, Fong
Y
, Hesse
DG
, Manogue
KR
, Lee
AT
, Kuo
GC
, Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia
. Nature
. 1987 Dec 17–23
;330
(6149
):662
. .46.
Ledo
C
, Gonzalez
CD
, Poncini
CV
, Mollerach
M
, Gómez
MI
. TNFR1 signaling contributes to T cell anergy during Staphylococcus aureus sepsis
. Front Cell Infect Microbiol
. 2018
;8
:259
. .47.
Hu
X
, Li
B
, Li
X
, Zhao
X
, Wan
L
, Lin
G
, Transmembrane TNF-α promotes suppressive activities of myeloid-derived suppressor cells via TNFR2
. J Immunol
. 2014
;192
(3
):1320
–31
. .48.
Zhao
X
, Rong
L
, Zhao
X
, Li
X
, Liu
X
, Deng
J
, TNF signaling drives myeloid-derived suppressor cell accumulation
. J Clin Invest
. 2012
;122
(11
):4094
–104
. .49.
McPeak
MB
, Youssef
D
, Williams
DA
, Pritchett
C
, Yao
ZQ
, McCall
CE
, Myeloid cell-specific knockout of NFI-A improves sepsis survival
. Infect Immun
. 2017
;85
(4
):e00066
–17
. .50.
Wang
Z
, Till
B
, Gao
Q
. Chemotherapeutic agent-mediated elimination of myeloid-derived suppressor cells
. Oncoimmunology
. 2017
;6
(7
):e1331807
. .51.
Tian
J
, Rui
K
, Tang
X
, Ma
J
, Wang
Y
, Tian
X
, MicroRNA-9 regulates the differentiation and function of myeloid-derived suppressor cells via targeting Runx1
. J Immunol
. 2015
;195
(3
):1301
–11
. .52.
Han
Y-C
, Park
CY
, Bhagat
G
, Zhang
J
, Wang
Y
, Fan
J-B
, microRNA-29a induces aberrant self-renewal capacity in hematopoietic progenitors, biased myeloid development, and acute myeloid leukemia
. J Exp Med
. 2010
;207
(3
):475
–89
. .53.
Xu
Z
, Ji
J
, Xu
J
, Li
D
, Shi
G
, Liu
F
, MiR-30a increases MDSC differentiation and immunosuppressive function by targeting SOCS3 in mice with B-cell lymphoma
. FEBS J
. 2017
;284
(15
):2410
–24
. .54.
Li
L
, Zhang
J
, Diao
W
, Wang
D
, Wei
Y
, Zhang
CY
, MicroRNA-155 and MicroRNA-21 promote the expansion of functional myeloid-derived suppressor cells
. J Immunol
. 2014
;192
(3
):1034
–43
. .55.
Boldin
MP
, Taganov
KD
, Rao
DS
, Yang
L
, Zhao
JL
, Kalwani
M
, miR-146a is a significant brake on autoimmunity, myeloproliferation, and cancer in mice
. J Exp Med
. 2011
;208
(6
):1189
–201
. .56.
McClure
C
, Brudecki
L
, Ferguson
DA
, Yao
ZQ
, Moorman
JP
, McCall
CE
, MicroRNA 21 (miR-21) and miR-181b couple with NFI-A to generate myeloid-derived suppressor cells and promote immunosuppression in late sepsis
. Infect Immun
. 2014
;82
(9
):3816
–25
. .57.
Dai
J
, Kumbhare
A
, Youssef
D
, Yao
ZQ
, McCall
CE
, El Gazzar
M
. Expression of C/EBPβ in myeloid progenitors during sepsis promotes immunosuppression
. Mol Immunol
. 2017
;91
:165
–72
. .58.
Fontana
L
, Pelosi
E
, Greco
P
, Racanicchi
S
, Testa
U
, Liuzzi
F
, MicroRNAs 17-5p-20a-106a control monocytopoiesis through AML1 targeting and M-CSF receptor upregulation
. Nat Cell Biol
. 2007
;9
(7
):775
. .59.
Noman
MZ
, Janji
B
, Hu
S
, Wu
JC
, Martelli
F
, Bronte
V
, Tumor-promoting effects of myeloid-derived suppressor cells are potentiated by hypoxia-induced expression of miR-210
. Cancer Res
. 2015
;75
(18
):3771
–87
. .60.
Cantoni
C
, Cignarella
F
, Ghezzi
L
, Mikesell
B
, Bollman
B
, Berrien-Elliott
MM
, Mir-223 regulates the number and function of myeloid-derived suppressor cells in multiple sclerosis and experimental autoimmune encephalomyelitis
. Acta Neuropathol
. 2017
;133
(1
):61
–77
. .61.
Liu
Y
, Lai
L
, Chen
Q
, Song
Y
, Xu
S
, Ma
F
, MicroRNA-494 is required for the accumulation and functions of tumor-expanded myeloid-derived suppressor cells via targeting of PTEN
. J Immunol
. 2012
;188
(11
):5500
–10
. .62.
Rosa
A
, Ballarino
M
, Sorrentino
A
, Sthandier
O
, De Angelis
FG
, Marchioni
M
, The interplay between the master transcription factor PU. 1 and miR-424 regulates human monocyte/macrophage differentiation
. Proc Natl Acad Sci U S A
. 2007
;104
:19849
–54
.63.
Hegde
VL
, Tomar
S
, Jackson
A
, Rao
R
, Yang
X
, Singh
UP
, Distinct microRNA expression profile and targeted biological pathways in functional myeloid-derived suppressor cells induced by Δ9-tetrahydrocannabinol in vivo
. J Biol Chem
. 2013
;288
(52
):36810
–26
. .64.
Dai
J
, Kumbhare
A
, Williams
DA
, Youssef
D
, Yao
ZQ
, McCall
CE
, Nfia deletion in myeloid cells blocks expansion of myeloid-derived suppressor cells during sepsis
. Innate Immun
. 2018
;24
(1
):54
–65
. .65.
Sheng
B
, Zhao
L
, Zang
X
, Zhen
J
, Chen
W
. miR-375 ameliorates sepsis by downregulating miR-21 level via inhibiting JAK2-STAT3 signaling
. Biomed Pharmacother
. 2017
;86
:254
–61
. .66.
McClure
C
, McPeak
MB
, Youssef
D
, Yao
ZQ
, McCall
CE
, El Gazzar
M
. Stat3 and C/EBPβ synergize to induce miR-21 and miR-181b expression during sepsis
. Immunol Cell Biol
. 2017
;95
(1
):42
–55
. .67.
Poon
D
, Anderson
BO
, Chen
LT
, Tanaka
K
, Lau
WY
, Van Cutsem
E
, Management of hepatocellular carcinoma in Asia: consensus statement from the Asian Oncology Summit 2009
. Lancet Oncol
. 2009
;10
(11
):1111
–8
. .68.
Youn
JI
, Collazo
M
, Shalova
IN
, Biswas
SK
, Gabrilovich
DI
. Characterization of the nature of granulocytic myeloid-derived suppressor cells in tumor-bearing mice
. J Leukoc Biol
. 2012
;91
(1
):167
–81
. .69.
Condamine
T
, Dominguez
GA
, Youn
JI
, Kossenkov
AV
, Mony
S
, Alicea-Torres
K
, Lectin-type oxidized LDL receptor-1 distinguishes population of human polymorphonuclear myeloid-derived suppressor cells in cancer patients
. Sci Immunol
. 2016
;1
(2
):aaf8943
. .70.
Lee
WC
, Wang
YC
, Cheng
CH
, Wu
TH
, Lee
CF
, Wu
TJ
, Myeloid-derived suppressor cells in the patients with liver resection for hepatitis B virus-related hepatocellular carcinoma
. Sci Rep
. 2019
;9
(1
):2269
. .71.
Huang
H
, Zhang
G
, Li
G
, Ma
H
, Zhang
X
. Circulating CD14(+)HLA-DR(−/low) myeloid-derived suppressor cell is an indicator of poor prognosis in patients with ESCC
. Tumour Biol
. 2015
;36
(10
):7987
–96
. .72.
Hu
B
, Yang
XR
, Xu
Y
, Sun
YF
, Sun
C
, Guo
W
, Systemic immune-inflammation index predicts prognosis of patients after curative resection for hepatocellular carcinoma
. Clin Cancer Res
. 2014
;20
(23
):6212
–22
. .73.
Chiu
DK
, Xu
IM
, Lai
RK
, Tse
AP
, Wei
LL
, Koh
HY
, Hypoxia induces myeloid-derived suppressor cell recruitment to hepatocellular carcinoma through chemokine (C-C motif) ligand 26
. Hepatology
. 2016
;64
(3
):797
–813
. .74.
Chiu
DK
, Tse
AP
, Xu
IM
, Di Cui
J
, Lai
RK
, Li
LL
, Hypoxia inducible factor HIF-1 promotes myeloid-derived suppressor cells accumulation through ENTPD2/CD39L1 in hepatocellular carcinoma
. Nat Commun
. 2017
;8
(1
):517
. .75.
Zheng
X
, Zhou
Y
, Yi
X
, Chen
C
, Wen
C
, Ye
G
, IL-21 receptor signaling is essential for control of hepatocellular carcinoma growth and immunological memory for tumor challenge
. Oncoimmunology
. 2018
;7
(12
):e1500673
. .76.
Leist
M
, Single
B
, Castoldi
AF
, Kühnle
S
, Nicotera
P
. Intracellular adenosine triphosphate (ATP) concentration: a switch in the decision between apoptosis and necrosis
. J Exp Med
. 1997
;185
(8
):1481
–6
. .77.
Yan
G
, Zhao
H
, Zhang
Q
, Zhou
Y
, Wu
L
, Lei
J
, A RIPK3-PGE2 circuit mediates myeloid-derived suppressor cell-potentiated colorectal carcinogenesis
. Cancer Res
. 2018
;78
(19
):5586
–99
. .78.
Thevenot
PT
, Sierra
RA
, Raber
PL
, Al-Khami
AA
, Trillo-Tinoco
J
, Zarreii
P
, The stress-response sensor chop regulates the function and accumulation of myeloid-derived suppressor cells in tumors
. Immunity
. 2014
;41
(3
):389
–401
. .79.
Gao
Y
, Wang
T
, Li
Y
, Zhang
Y
, Yang
R
. Lnc-chop promotes immunosuppressive function of myeloid-derived suppressor cells in tumor and inflammatory environments
. J Immunol
. 2018
;200
(8
):2603
–14
. .80.
Ma
G
, Pan
PY
, Eisenstein
S
, Divino
CM
, Lowell
CA
, Takai
T
, Paired immunoglobin-like receptor-B regulates the suppressive function and fate of myeloid-derived suppressor cells
. Immunity
. 2011
;34
(3
):385
–95
. .81.
De Goeje
PL
, Bezemer
K
, Heuvers
ME
, Dingemans
AC
, Groen
HJ
, Smit
EF
, Immunoglobulin-like transcript 3 is expressed by myeloid-derived suppressor cells and correlates with survival in patients with non-small cell lung cancer
. Oncoimmunology
. 2015
;4
(7
):e1014242
. .82.
Jang
HS
, Shin
WJ
, Lee
JE
, Do
JT
. CpG and non-CpG methylation in epigenetic gene regulation and brain function
. Genes
. 2017
;8
(6
):148
. .83.
Youn
JI
, Kumar
V
, Collazo
M
, Nefedova
Y
, Condamine
T
, Cheng
P
, Epigenetic silencing of retinoblastoma gene regulates pathologic differentiation of myeloid cells in cancer
. Nat Immunol
. 2013
;14
(3
):211
. .84.
Rodrıguez-Ubreva
J
, Català-Moll
F
, Obermajer
N
, Álvarez-Errico
D
, Ramirez
RN
; Carlos Company
, Prostaglandin E2 leads to the acquisition of DNMT3A-dependent tolerogenic functions in human myeloid-derived suppressor cells
. Cell Rep
. 2017
;21
:154
–67
.85.
Redd
PS
, Ibrahim
ML
, Klement
JD
, Sharman
SK
, Paschall
AV
, Yang
D
, SETD1B activates iNOS expression in myeloid-derived suppressor cells
. Cancer Res
. 2017
;77
(11
):2834
–43
. .86.
Marks
PA
. Histone deacetylase inhibitors: a chemical genetics approach to understanding cellular functions
. Biochim Biophys Acta
. 2010
;1799
(10–12
):717
–25
. .87.
Marks
PA
, Xu
WS
. Histone deacetylase inhibitors: potential in cancer therapy
. J Cell Biochem
. 2009
;107
(4
):600
–8
. .88.
Jeltsch
A
. Molecular enzymology of mammalian DNA methyltransferases
. Curr Top Microbiol Immunol
. 2006
;301
:203
–25
. .89.
Li
X
, Zhang
Q
, Ding
Y
, Liu
Y
, Zhao
D
, Zhao
K
, Methyltransferase Dnmt3a upregulates HDAC9 to deacetylate the kinase TBK1 for activation of antiviral innate immunity
. Nat Immunol
. 2016
;17
(7
):806
. .90.
Sarkar
S
, Abujamra
AL
, Loew
JE
, Forman
LW
, Perrine
SP
, Faller
DV
. Histone deacetylase inhibitors reverse CpG methylation by regulating DNMT1 through ERK signaling
. Anticancer Res
. 2011
;31
(9
):2723
–32
.91.
Hashimoto
A
, Fukumoto
T
, Zhang
R
, Gabrilovich
D
. Selective targeting of different populations of myeloid-derived suppressor cells by histone deacetylase inhibitors
. Cancer Immunol Immunother
. 2020
;69
(9
):1929
–36
. .92.
Bardai
FH
, Price
V
, Zaayman
M
, Wang
L
, D’Mello
SR
. Histone deacetylase-1 (HDAC1) is a molecular switch between neuronal survival and death
. J Biol Chem
. 2012
;287
:35444
–53
.93.
Winter
M
, Moser
MA
, Meunier
D
, Fischer
C
, Machat
G
, Mattes
K
, Divergent roles of HDAC1 and HDAC2 in the regulation of epidermal development and tumorigenesis
. EMBO J
. 2013
;32
(24
):3176
–91
. .94.
Miller
KM
, Tjeertes
JV
, Coates
J
, Legube
G
, Polo
SE
, Britton
S
, Human HDAC1 and HDAC2 function in the DNA-damage response to promote DNA nonhomologous end-joining
. Nat Struct Mol Biol
. 2010
;17
(9
):1144
. .95.
Guan
JS
, Haggarty
SJ
, Giacometti
E
, Dannenberg
JH
, Joseph
N
, Gao
J
, HDAC2 negatively regulates memory formation and synaptic plasticity
. Nature
. 2009
;459
(7243
):55
. .96.
Lu
X-F
, Cao
X-Y
, Zhu
Y-J
, Wu
Z-R
, Zhuang
X
, Shao
M-Y
, Histone deacetylase 3 promotes liver regeneration and liver cancer cells proliferation through signal transducer and activator of transcription 3 signaling pathway
. Cell Death Dis
. 2018
;9
(3
):398
. .97.
Liu
C
, Liu
L
, Shan
J
, Shen
J
, Xu
Y
, Zhang
Q
, Histone deacetylase 3 participates in self-renewal of liver cancer stem cells through histone modification
. Cancer Lett
. 2013
;339
(1
):60
–9
. .98.
Sun
Z
, Miller
RA
, Patel
RT
, Chen
J
, Dhir
R
, Wang
H
, Hepatic Hdac3 promotes gluconeogenesis by repressing lipid synthesis and sequestration
. Nat Med
. 2012
;18
(6
):934
. .99.
Han
X
, Hao
C
, Li
L
, Li
J
, Fang
M
, Zheng
Y
, HDAC4 stimulates MRTF-A expression and drives fibrogenesis in hepatic stellate cells by targeting miR-206
. Oncotarget
. 2017
;8
(29
):47586
. .100.
Barbier-Torres
L
, Beraza
N
, Fernández-Tussy
P
, Lopitz-Otsoa
F
, Fernández-Ramos
D
, Zubiete-Franco
I
, Histone deacetylase 4 promotes cholestatic liver injury in the absence of prohibitin-1
. Hepatology
. 2015
;62
(4
):1237
–48
. .101.
Geng
H
, Harvey
CT
, Pittsenbarger
J
, Liu
Q
, Beer
TM
, Xue
C
, HDAC4 protein regulates HIF1α protein lysine acetylation and cancer cell response to hypoxia
. J Biol Chem
. 2011
;286
(44
):38095
–102
. .102.
Qiu
X
, Li
J
, Lv
S
, Yu
J
, Jiang
J
, Yao
J
, HDAC5 integrates ER stress and fasting signals to regulate hepatic fatty acid oxidation
. J Lipid Res
. 2018
;59
(2
):330
–8
. .103.
Li
Y
, Shin
D
, Kwon
SH
. Histone deacetylase 6 plays a role as a distinct regulator of diverse cellular processes
. FEBS J
. 2013
;280
(3
):775
–93
. .104.
Ding
G
, Liu
HD
, Huang
Q
, Liang
HX
, Ding
ZH
, Liao
ZJ
, HDAC6 promotes hepatocellular carcinoma progression by inhibiting P53 transcriptional activity
. FEBS Lett
. 2013
;587
(7
):880
–6
. .105.
Barneda-Zahonero
B
, Román-González
L
, Collazo
O
, Rafati
H
, Islam
AB
, Bussmann
LH
, HDAC7 is a repressor of myeloid genes whose downregulation is required for transdifferentiation of pre-B cells into macrophages
. PLoS Genet
. 2013
;9
(5
):e1003503
. .106.
Tian
Y
, Wong
VW
, Wong
GL
, Yang
W
, Sun
H
, Shen
J
, Histone deacetylase HDAC8 promotes insulin resistance and β-catenin activation in NAFLD-associated hepatocellular carcinoma
. Cancer Res
. 2015
;75
(22
):4803
–16
. .107.
Chen
J
, Zhang
Z
, Wang
N
, Guo
M
, Chi
X
, Pan
Y
, Role of HDAC9-FoxO1 axis in the transcriptional program associated with hepatic gluconeogenesis
. Sci Rep
. 2017
;7
(1
):6102
. .108.
ChatterjeeTK
, Basford
JE
, Yiew
KH
, Stepp
DW
, Hui
DY
, Weintraub
NL
. Role of histone deacetylase 9 in regulating adipogenic differentiation and high fat diet-induced metabolic disease
. Adipocyte
. 2014
;3
:333
–8
.109.
Tao
X
, Yan
Y
, Lu
L
, Chen
B
. HDAC10 expression is associated with DNA mismatch repair gene and is a predictor of good prognosis in colon carcinoma
. Oncol Lett
. 2017
;14
(4
):4923
–9
. .110.
Bhaskara
S
. Histone deacetylase 11 as a key regulator of metabolism and obesity
. EBioMedicine
. 2018
;35
:27
–8
. .111.
Bala
S
, Csak
T
, Kodys
K
, Catalano
D
, Ambade
A
, Furi
I
, Alcohol-induced miR-155 and HDAC11 inhibit negative regulators of the TLR4 pathway and lead to increased LPS responsiveness of Kupffer cells in alcoholic liver disease
. J Leukoc Biol
. 2017
;102
(2
):487
–98
. .112.
Villagra
A
, Cheng
F
, Wang
HW
, Suarez
I
, Glozak
M
, Maurin
M
, The histone deacetylase HDAC11 regulates the expression of interleukin 10 and immune tolerance
. Nat Immunol
. 2009
;10
(1
):92
. .113.
Sahakian
E
, Powers
JJ
, Chen
J
, Deng
SL
, Cheng
F
, Distler
A
, Histone deacetylase 11: A novel epigenetic regulator of myeloid derived suppressor cell expansion and function
. Mol Immunol
. 2015
;63
(2
):579
–85
. .114.
Sahakian
E
, Chen
J
, Powers
JJ
, Chen
X
, Maharaj
K
, Deng
SL
, Essential role for histone deacetylase 11 (HDAC11) in neutrophil biology
. J Leukoc Biol
. 2017
;102
(2
):475
–86
. .© 2021 S. Karger AG, Basel
2021
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.
